Immunochina

About:

Immunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.

Website: http://www.immunochina.com/

Top Investors: Foothill Ventures, Legend Capital, SDIC Venture Capital, Zhongguancun Science City Science, Sherpa Healthcare Partners

Description:

ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

Total Funding Amount:

$45.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Beijing, Beijing, China

Founded Date:

2015-04-01

Contact Email:

office(AT)immunochina.com

Founders:

He Ting

Number of Employees:

101-250

Last Funding Date:

2023-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai